Partnering with Takeda Oncology
From early-stage research to ensuring patients can access our medicines, we complement our deep in-house expertise with collaborators who share our aspiration to cure cancer and can enable us to more effectively address the needs of patients.
Takeda Oncology seeks partnerships for novel first-in-class and / or best-in-class discovery and clinical stage oncology programs that would meet patient needs and complement Takeda’s research expertise and global commercial footprint in hematological malignancies and solid tumors, with a particular focus on lung cancer and gastrointestinal cancers.
Takeda Oncology’s discovery and development efforts are focused on working with world-class teams to explore transformational approaches leveraging the innate immune system. We seek innovative technologies and next-generation platforms to augment and expand this research in an effort to outsmart cancer.
If interested in partnering with Takeda Oncology, please reach out to our team at [email protected].